// App-Quantinova.ai

P921 : UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

Researchers

Presenter

  • Joaqun Martnez-Lpez

Principal Investigators

  • Saad Z Usmani

  • Alfred Garfall

  • Niels WCJ van de Donk

  • Jess F San-Miguel

  • Albert Oriol

  • Ajai Chari

  • Lionel Karlin

  • Maria-Victoria Mateos

  • Rakesh Popat

  • Ajay K Nooka

  • Surbhi Sidana

  • Raluca Verona

  • Suzette Girgis

  • Clarissa Uhlar

  • Tara Stephenson

  • Arnob Banerjee

  • Amrita Krishnan

Medical Centers

  • Abramson Cancer Center, Perelman School of Medicine, University

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Mount Sinai School of Medicine, New York, NY

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Stanford University School of Medicine,Stanford, CA,Verenigde Staten

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Mount Sinai School of Medicine, New York, NY

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • Development, LLC,Raritan, NJ,États-unis

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Development,Raritan, NJ,Vereinigte Staaten

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Stanford School of Medicine, Stanford, CA

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Hematology Biology, University Hospital Hotel Dieu, Nantes, France

  • City of Hope Cancer Center,Duarte,United States

  • Development, LLC,Spring House, PA,Estados Unidos

  • City of Hope Cancer Center,Duarte,United States

  • Development,Spring Hou

  • Stanford University School of Medicine,Stanford,Estados Unidos

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Janssen Research &amp

  • Stanford School of Medicine, Stanford, CA, United States

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Winship Cancer Institute, Emory University Hospital,Atlanta, GA,Vereinigte Staaten

  • Mount Sinai School of Medicine,New York, NY,Estados Unidos

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Jansse

  • University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • Development, LLC,Spring House,United States

  • Mount Sinai Icahn School of Medicine, New York, New York, United States

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • City of Hope Cancer Center,Duarte,United States

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Stanford School of Medicine, Stanford, CA

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Development,Raritan,United States

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • Abramson Cancer Center and University of Pennsylvania,Philadelphia, PA,États-unis

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Stanford University School of Medicine,Stanford, CA,Verenigde Staten

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Amsterdam University Medical Center, Vrije Unive

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Clínica Universidad de Navarra, CIMA, CIBERO

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Development, LLC,Spring House,United States

  • Mount Sinai School of Medicine, New York, NY

  • Development,Raritan,Estados Unidos

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Development,Spring House,États-unis

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Development,Raritan, NJ,Vereinigte Staaten

  • Development,Spring House, PA,Stati Uniti

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Development,Raritan,Stati Uniti

Locations

  • Spain

  • France

  • United States

  • Venezuela

  • Mexico

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Cytokine release syndrome

Biomarkers

  • Cluster of Differentiation 2AP

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • NCT03145181

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved